{"entity":{"id":"nct07189455","kind":"trial","name":"Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer","aka":[],"tldr":"A phase 3 trial testing ZG006 in non-small-cell lung cancer, now recruiting.","summary":"Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer is a phase 3 interventional study registered as NCT07189455, led by Suzhou Zelgen Biopharmaceuticals, and recruiting on the registry. Official title: A Multicenter, Randomised, Controlled, Open-Label Phase III Study Evaluating the Efficacy and Safety of ZG006 for Injection Compared With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer. Planned enrolment is 420 participants (estimated). The study started in 2025-12-12 and primary completion is expected in 2028-10. No results have been posted on ClinicalTrials.gov.","status":"recruiting","asOf":"2026-09-11","links":[{"label":"ClinicalTrials.gov NCT07189455","url":"https://clinicaltrials.gov/study/NCT07189455"}],"tags":["ctgov-ingest"],"related":[],"cancers":["nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":["zg006"],"companies":["zelgen"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07189455","phase":"3","setting":"A Multicenter, Randomized, Controlled, Open-Label Phase III Study Evaluating the Efficacy and Safety of ZG006 for Injection Compared With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer","sponsor":"Suzhou Zelgen Biopharmaceuticals","participation":[{"nct":"NCT07189455","source":"https://clinicaltrials.gov/study/NCT07189455","fetchedAt":"2026-10-07T16:55:32.313Z","studySha256":"8aee27d246056d27ad2b7e1a49c73a4c3f841411ddba30eff3732c41e8f12554","overallStatus":"RECRUITING","lastUpdatePosted":"2026-01-05","leadSponsor":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","collaboratorCount":0,"minimumAge":"18 Years","maximumAge":"75 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":420,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":1,"countries":["China"]}],"started":"2025-12-12","startedType":"actual","enrolled":420,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07189455/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"drug":[{"id":"zg006","kind":"drug","name":"ZG006","route":"/drugs/zg006/"}],"company":[{"id":"zelgen","kind":"company","name":"Suzhou Zelgen Biopharmaceuticals","route":"/companies/zelgen/"}]}}